State-of-the-art vs. the leading edge in colon cancer race

State-of-the-art vs. the leading edge in colon cancer race

A race to identify a gene responsible for colon cancer ended in a dead heat last week, as a low-key lab at Harvard's Dana-Farber Cancer Center used old-fashioned networking and DNA probes to keep pace with Human Genome Sciences Inc.'s automated gene sequencing